The Extended Dwell Peripheral Intravenous Catheter Is an Alternative Method of NICU Intravenous Access

Kimberlee B Chenoweth, Jia-Wen Guo, Belinda Chan, Kimberlee B Chenoweth, Jia-Wen Guo, Belinda Chan

Abstract

Background: Establishing vascular access is a common neonatal intensive care unit procedure. The extended dwell peripheral intravenous (EPIV) catheter is a 6-cm and 8-cm silicone catheter for peripheral vein insertion, which is a newer vascular access device than peripherally inserted central catheters (PICCs) and peripheral intravenous (PIV) catheter. Extended dwell peripheral intravenous catheters have been widely used in adults but evidence in neonates is lacking.

Purpose: To explore indwell time, success rate, catheter-associated complications, and cost among EPIV catheters, PICCs, and PIV catheters in neonates.

Methods: We retrospectively compare patient demographics, indwell time, success rate, and catheter-associated complications, and analyze the rate of hyaluronidase-treated intravenous (IV) fluid extravasation on neonates who had an EPIV catheter, a PICC, or a PIV catheter in a level III neonatal intensive care unit. We also estimate the insertion cost of these 3 vascular access devices on the basis of our hospital charges.

Results: Extended dwell peripheral intravenous catheters were inserted in 432 neonates with an indwell time of 4.0 ± 2.3 (mean ± SD) days. Peripherally inserted central catheters were inserted in 202 neonates with an average indwell time of 7.3 ± 4.4 (mean ± SD) days, which was longer than EPIV catheters (P < .001). Peripherally inserted central catheters had a higher success rate of 83.6% than 71.7% of EPIV catheters, meaning succeeded in lasting through the completion of therapy (P = .001). Peripherally inserted central catheters were associated with 4 cases of life-threatening complications; none was seen in the EPIV catheter group. The incidence of hyaluronidase-treated IV fluid extravasation was less in EPIV catheter recipients (1.2%) than in the PIV catheter recipients (3.9%) (P = .004); none was in the PICC group. Cost savings were noted with using an EPIV catheter.

Implications for practice: Extended dwell peripheral intravenous catheter is a feasible option for neonatal vascular access.

Implications for research: These data provide a baseline for future studies to explore the efficacy and effectiveness of EPIV catheter in the neonates.

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
FIGURE 2
FIGURE 2
FIGURE 3
FIGURE 3

References

    1. Wyckoff MM. Midline catheter use in the premature and full-term infant. J Assoc Vasc Access. 1999;4(3):26–29.
    1. Ainsworth S, McGuire W. Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates. Cochrane Database Syst Rev. 2015;(10):CD004219. 10.1002/14651858.CD004219.pub4.
    1. Romesber TL. Evaluating the evidence for midline catheter use in the newborn intensive care unit. J Infus Nurs. 2015;38(6):420–429. 10.1097/NAN.0000000000000134.
    1. Ramasethu J. Complications of vascular catheters in the neonatal intensive care unit. Clin Perinatol. 2008;35(1):199–222. 10.1016/j.clp.2007.11.007.
    1. Pettit J. Technological advances for PICC placement and management. Adv Neonatal Care. 2007;7(3):122–131.
    1. Colacchio K, Deng Y, Northrup V, Bizzarro MJ. Complications associated with central and non-central venous catheters in a neonatal intensive care unit. J Perinatol. 2012;32(12):941–946. 10.1038/jp.2012.7.
    1. Pettit J. Assessment of infants with peripherally inserted central catheters: part 2. Detecting less frequently occurring complications. Adv Neonatal Care. 2003;3(1):14–26.
    1. Nadroo AM, Lin J, Green RS, Magid MS, Holzman IR. Death as a complication of peripherally inserted central catheters in neonates. J Pediatr. 2001;138(4):599–601.
    1. Franck LS, Hummel D, Connell K, Quinn D, Montgomery J. The safety and efficacy of peripheral intravenous catheters in ill neonates. Neonatal Netw. 2001;20(5):33–38.
    1. Dawson D. Midline catheters in neonatal patients: evaluating a change in practice. J Assoc Vasc Access. 2002;7(2):17–19.
    1. Leick-Rude MK, Haney B. Midline catheter use in the intensive care nursery. Neonatal Netw. 2006;25(3):189–199.
    1. Lesser E, Chhabra R, Brion LP, Suresh BR. Use of midline catheters in low birth weight infants. J Perinatol. 1996;16(3, pt 1): 205–207.
    1. Tobin CR. The Teflon intravenous catheter: incidence of phlebitis and duration of catheter life in the neonatal patient. J Obstet Gynecol Neonatal Nurs. 1988;17(1):35–42. 10.1111/j.1552-6909.1988.tb00412.x.
    1. Smith AB, Wilkinson-Faulk D. Factors affecting the life span of peripheral intravenous lines in hospitalized infants. Pediatr Nurs. 1994;20(6):543–547.
    1. McCullen KL, Peiper B. A retrospective chart review of risk factors for extravasation among neonates receiving peripheral intravascular fluids. J Wound Ostomy Continence Nurs. 2006;33(2):133–139.
    1. Restieaux M, Maw A, Broadbent R, Jackson P, Barker D, Wheeler B. Neonatal extravasation injury: prevention and management in Australia and New Zealand-a survey of current practice. BMC Pediatr. 2013;13:34. 11.1186/1471-2431-13-34.
    1. Yan Y-M, Fan Q-L, Li A-Q, Chen J-L, Dong F-F, Gong M. Treatment of cutaneous injuries of neonates induced by drug extravasation with hyaluronidase and hirudoid. Iranian J Pediatr. 2014;24(4):352–358.
    1. Alexandrou E, Jamjan LM, Spencer T, Forst SA, Salamonson DP. The use of midline catheters in the adult acute care setting—clinical implications and recommendation for practice. J Assoc Vasc Access. 2011;16(1):35–41.
    1. Wood M. Improving patient comfort by increasing completion of therapy rates with fewer risks for patients through the use of midline catheters. J Assoc Vasc Access. 2015;20(4):250. 10.1016/j.java.2015.10.043.
    1. Moran MA. Introducing the midline catheter as a new intravenous access device in neonates. Neonatal Intensive Care. 1992;5(3):36–42.
    1. NeoMagic [product brochure]. Sparks, NV: Neo Medical Inc; 2011.
    1. Gorski L, Hadaway L, Hagle ME, McGoldrick M, Orr M, Doellman D. Infusion therapy: standards of practice. J Infus Nurs. 2016;39(1S):S52.
    1. Clark E, Giambra B, Hingl J, Doellman D, Tofani B, Johnson N. Reducing risk of harm from extravasation: a 3-tiered evidence-based list of pediatric peripheral intravenous infusates. J Infus Nurs. 2013;36(1):37–45. 10.1097/NAN.0b013e3182798844.
    1. Anderson NR. Midline catheters: the middle ground of intravenous therapy administration. J Infus Nurs. 2004;27(5):313–321.
    1. Reynolds J. Comparison of percutaneous venous catheters and Teflon catheters for intravenous therapy in neonates. Neonatal Netw. 1993;12(5):33–39.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera